[HTML][HTML] Effectiveness of curcumin on outcomes of hospitalized COVID-19 patients: A systematic review of clinical trials

A Vahedian-Azimi, M Abbasifard, F Rahimi-Bashar… - Nutrients, 2022 - mdpi.com
Despite the ongoing vaccination efforts, there is still an urgent need for safe and effective
treatments to help curb the debilitating effects of COVID-19 disease. This systematic review …

[HTML][HTML] The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a …

G Askari, A Sahebkar, D Soleimani, A Mahdavi… - Trials, 2022 - Springer
Background COVID-19 pandemic has made the disease a major global problem by creating
a significant burden on health, economic, and social status. To date, there are no effective …

Curcumin, a traditional spice component, can hold the promise against COVID-19?

VK Soni, A Mehta, YK Ratre, AK Tiwari, A Amit… - European Journal of …, 2020 - Elsevier
The severity of the recent pandemic and the absence of any specific medication impelled the
identification of existing drugs with potential in the treatment of Coronavirus disease-2019 …

[HTML][HTML] Oral curcumin with piperine as adjuvant therapy for the treatment of COVID-19: A randomized clinical trial

KS Pawar, RN Mastud, SK Pawar, SS Pawar… - Frontiers in …, 2021 - frontiersin.org
Background: Coronavirus disease-2019 (COVID-19) has a wide range of pathophysiological
effects. Curcumin, an active constituent of Curcuma longa (turmeric), has several properties …

[HTML][HTML] Curcumin confers anti-inflammatory effects in adults who recovered from COVID-19 and were subsequently vaccinated: a randomized controlled trial

SN Fessler, Y Chang, L Liu, CS Johnston - Nutrients, 2023 - mdpi.com
COVID-19 infection and vaccination offer disparate levels of defense against reinfection and
breakthrough infection. This study was designed to examine the effects of curcumin …

[HTML][HTML] Curcumin as a potential treatment for COVID-19

BAC Rattis, SG Ramos, MRN Celes - Frontiers in pharmacology, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is an infectious disease that rapidly spread
throughout the world leading to high mortality rates. Despite the knowledge of previous …

The effectiveness of nano‐curcumin on patients with COVID‐19: A systematic review of clinical trials

M Shojaei, S Foshati, M Abdi, G Askari… - Phytotherapy …, 2023 - Wiley Online Library
The main aim of the current study was to summarize the findings of available clinical studies
to assess nano‐curcumin's influence on COVID patients. A comprehensive online search …

Oral nano‐curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease‐19 patients: An open label nonrandomized clinical trial

N Saber‐Moghaddam, S Salari, S Hejazi… - Phytotherapy …, 2021 - Wiley Online Library
Curcumin is proposed as a potential treatment option for coronavirus disease‐19 (COVID‐
19) by inhibiting the virus entrance, encapsulation and replication, and modulating various …

Promising clinical outcomes of nano‐curcumin treatment as an adjunct therapy in hospitalized COVID‐19 patients: A randomized, double‐blinded, placebo‐controlled …

M Sadeghizadeh, E Asadollahi… - Phytotherapy …, 2023 - Wiley Online Library
Different immunomodulation strategies have been used to manage COVID‐19 due to the
complex immune‐inflammatory processes involved in the pathogenesis of this infection …

Potential effects of curcumin in the treatment of COVID‐19 infection

F Zahedipour, SA Hosseini, T Sathyapalan… - Phytotherapy …, 2020 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) outbreak is an ongoing pandemic caused
by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with considerable …